XLON
DPLM
Market cap12bUSD
Jul 09, Last price
6,750.00GBP
1D
0.97%
1Q
0.75%
Jan 2017
549.66%
Name
Diploma PLC
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Diploma PLC is a global provider of highly specialized technical products and services, operating across the United Kingdom, Europe, North America, and other international markets. The company structures its diverse operations into three primary business sectors: Life Sciences, Seals, and Controls. The Life Sciences division caters to healthcare and scientific research institutions, offering a comprehensive suite of clinical diagnostics instrumentation, related consumables, and specialized surgical equipment for hospitals, clinics, and pathology laboratories. It also provides advanced patient monitoring technologies, laboratory diagnostics, and medically supervised nutritional products. Additionally, this segment supplies specialized containment solutions and analytical tools vital for the chemical, petrochemical, environmental research, and pharmaceutical industries. The Seals sector specializes in critical sealing technologies. It provides a wide array of seals, gaskets, filters, hydraulic cylinders, and various components, including O-rings and custom-engineered parts, primarily serving heavy mobile machinery, industrial equipment, and fluid sealing applications. Lastly, the Controls segment offers a broad portfolio of connectivity and control solutions. This includes products for cable identification, termination, and management, low-voltage cables, and a variety of harness components and specialist connectors, often bundled with technical support and automated inventory services for demanding sectors like civil aerospace, motorsport, and defense. Furthermore, this division supplies fluid controllers, compressors, valves, temperature and pressure measurement devices, liquid dispensing components, and industrial silicones, adhesives, and sealants. Diploma PLC was incorporated in 1931 and is based in London, United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||